Facebook Pixel ‘Fit and proper’ fine-tuned | Financial Express Mumbai - newspaper - इस कहानी को Magzter.com पर पढ़ें
मैगज़्टर गोल्ड के साथ असीमित हो जाओ

मैगज़्टर गोल्ड के साथ असीमित हो जाओ

10,000 से अधिक पत्रिकाओं, समाचार पत्रों और प्रीमियम कहानियों तक असीमित पहुंच प्राप्त करें सिर्फ

$149.99
 
$74.99/वर्ष

कोशिश गोल्ड - मुक्त

‘Fit and proper’ fine-tuned

Financial Express Mumbai

|

March 20, 2026

SEBI'S PROPOSAL IS COMMENDABLE FOR SEEKING TO BALANCE REGULATORY RIGOUR WITH PROCEDURAL FAIRNESS

- SANDEEP PAREKH

THE SECURITIES MARKET operates on public funds and is exposed to systemic risk. Regulators therefore apply a “fit and proper” criterion to assess integrity, competence, reputation, and financial soundness before granting market access. This protects investors and sustains market trust and stability. The Securities and Exchange Board of India (Sebi), through a consultation paper, proposed amendments to the “fit and proper” framework under the Sebi (Intermediaries) Regulations, 2008, reflecting a nuanced attempt to contemporise regulatory standards.

At the heart of Sebi’s proposals is a selective relaxation of certain automatic, rule-based triggers for disqualification in favour of greater reliance on the existing principle-based criteria under the Intermediaries Regulations that aligns more closely with global norms and jurisprudential fairness. This recalibration is not merely semantic. It signals a subtle but important maturing of regulatory philosophy, one that recognises that the presumption of innocence and proportionality are essential to sustaining confidence in India’s capital markets.

Financial Express Mumbai

यह कहानी Financial Express Mumbai के March 20, 2026 संस्करण से ली गई है।

हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।

क्या आप पहले से ही ग्राहक हैं?

Financial Express Mumbai से और कहानियाँ

Financial Express Mumbai

Why VW is waiting for Indian grid to catch up

AUDI, SKODA, VOLKSWAGEN DON'T HAVE EVs IN INDIA

time to read

2 mins

March 21, 2026

Financial Express Mumbai

Easy to love, hard to beat

VERY GOOD RIDE & HANDLING, BUT DOESN'T HAVE ADAS SEMIAUTOMATIC DRIVING

time to read

1 mins

March 21, 2026

Financial Express Mumbai

Re breaches 93/$ as risks from long Iran war mount

THE ESCALATING CRISIS in West Asia continued to pressure the Indian rupee,which breached the 93 mark for the first time on Friday — the worst single-day fall in four years.

time to read

2 mins

March 21, 2026

Financial Express Mumbai

Hyundai tweaks Exter as entry SUV race shifts to image

HYUNDAI MOTOR INDIA on Friday rolled out an updated version of the Exter, but the significance of the move lies less in the launch itself and more in the shifting dynamics of the entry SUV segment, where pricing and features are no longer the primary differentiators.

time to read

2 mins

March 21, 2026

Financial Express Mumbai

A good fight amid lost wars

ABSENCE OF ONLY FORUM WHERE 193 NATIONS MEET MIGHT COST THE NEXT WAR A LOT MORE

time to read

4 mins

March 21, 2026

Financial Express Mumbai

Pinterest CEO calls for social media ban

PINTEREST CEO BILL Ready called on world leaders to ban social media for youth under 16 in a Linked In post on Friday.

time to read

1 min

March 21, 2026

Financial Express Mumbai

Tom Cruise, Brad Pitt can relax. Al won't kill movies

JUSTIN HACKNEY IS used to being ostracised.

time to read

3 mins

March 21, 2026

Financial Express Mumbai

Look for travel insurance that covers flight cancellations

REASSESS EFFICACY OF TRAVEL COVER IN ADDRESSING GEOPOLITICAL RISKS

time to read

2 mins

March 21, 2026

Financial Express Mumbai

Who really runs India’s digital markets?

Technology promised fewer middlemen but created new ones shaping markets, power, and citizens’ lives, raising question of sovereignty

time to read

3 mins

March 21, 2026

Financial Express Mumbai

Weight-loss drug prices down 70-90% as generics hit the shelves

IN A SHOT in the arm for India's high-growth weight-loss medicine market, generic versions of drugmaker Danish Novo Nordisk's blockbuster drug Semaglutide will hit the shelves on Saturday, with price discounts as deep as 70-90%.

time to read

2 mins

March 21, 2026

Listen

Translate

Share

-
+

Change font size